ANTISEROTONIN ACTION OF LSD-25 AND OTHER LYSERGIC ACID DERIVATIVES: FACT AND FICTION.
D001249:Asthma; D001321:Autistic Disorder; D002648:Child; D006213:Hallucinogens; D006801:Humans; D006967:Hypersensitivity; D008237:Lysergic Acid; D008238:Lysergic Acid Diethylamide; D008784:Methysergide; D008881:Migraine Disorders; D010600:Pharmacology; D012559:Schizophrenia; D012561:Schizophrenia, Childhood; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D014116:Toxicology
D006213:Hallucinogens; D008237:Lysergic Acid; D008238:Lysergic Acid Diethylamide; D008784:Methysergide; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors
ASTHMA; AUTISM; CHILD; HALLUCINOGENS; HYPERSENSITIVITY; LYSERGIC ACID DIETHYLAMIDE; METHYSERGIDE; MIGRAINE; PHARMACOLOGY; SCHIZOPHRENIA, CHILDHOOD; SEROTONIN INHIBITORS; TOXICOLOGIC REPORT